0GZV Stock Overview
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 0GZV from our risk checks.
Getinge AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr231.40 |
| 52 Week High | kr274.60 |
| 52 Week Low | kr174.50 |
| Beta | 0.56 |
| 1 Month Change | 11.14% |
| 3 Month Change | 4.56% |
| 1 Year Change | -12.61% |
| 3 Year Change | -17.24% |
| 5 Year Change | 73.40% |
| Change since IPO | 34.93% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0GZV | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 7.3% | -0.09% | -0.9% |
| 1Y | -12.6% | -10.7% | -1.8% |
Return vs Industry: 0GZV underperformed the UK Medical Equipment industry which returned -10.7% over the past year.
Return vs Market: 0GZV underperformed the UK Market which returned -1.8% over the past year.
Price Volatility
| 0GZV volatility | |
|---|---|
| 0GZV Average Weekly Movement | 5.0% |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0GZV has not had significant price volatility in the past 3 months.
Volatility Over Time: 0GZV's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1904 | 11,739 | Mattias Perjos | www.getinge.com |
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions.
Getinge AB (publ) Fundamentals Summary
| 0GZV fundamental statistics | |
|---|---|
| Market cap | kr63.03b |
| Earnings (TTM) | kr2.29b |
| Revenue (TTM) | kr32.20b |
27.6x
P/E Ratio2.0x
P/S RatioIs 0GZV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0GZV income statement (TTM) | |
|---|---|
| Revenue | kr32.20b |
| Cost of Revenue | kr17.59b |
| Gross Profit | kr14.61b |
| Other Expenses | kr12.32b |
| Earnings | kr2.29b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 18, 2024
| Earnings per share (EPS) | 8.39 |
| Gross Margin | 45.37% |
| Net Profit Margin | 7.10% |
| Debt/Equity Ratio | 20.1% |
How did 0GZV perform over the long term?
See historical performance and comparisonDividends
1.9%
Current Dividend Yield52%
Payout RatioDoes 0GZV pay a reliable dividends?
See 0GZV dividend history and benchmarks| Getinge dividend dates | |
|---|---|
| Ex Dividend Date | Apr 23 2024 |
| Dividend Pay Date | Apr 29 2024 |
| Days until Ex dividend | 1 day |
| Days until Dividend pay date | 5 days |
Does 0GZV pay a reliable dividends?
See 0GZV dividend history and benchmarks